Request Demo
Last update 08 May 2025
PDGFRα x FGFR1 x c-Kit x VEGFR1 x Flt3L x PDGFRβ x LCK x VEGFR3 x VEGFR2 x ITK x FGFR3
Last update 08 May 2025
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
ChiCTR2500096689
Evaluation of efficacy and safety of pazopanib combined with TGI/CIV(nab?Paclitaxel+ gemcitabine + isocyclophosphamide/cyclophosphamide +Irinotecan + vinorelbine) in the treatment for children or adolescents with recurrent/refractory rhabdomyosarcoma ——an open-label, single-arm, single-center,phase II clinical trial
100 Clinical Results associated with PDGFRα x FGFR1 x c-Kit x VEGFR1 x Flt3L x PDGFRβ x LCK x VEGFR3 x VEGFR2 x ITK x FGFR3
Login to view more data
100 Translational Medicine associated with PDGFRα x FGFR1 x c-Kit x VEGFR1 x Flt3L x PDGFRβ x LCK x VEGFR3 x VEGFR2 x ITK x FGFR3
Login to view more data
Login to view more data
Analysis
Perform a panoramic analysis of this field.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free